H.R.380 - Pharmaceutical Market Access and Drug Safety Act of 2007

To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. view all titles (2)

All Bill Titles

  • Short: Pharmaceutical Market Access and Drug Safety Act of 2007 as introduced.
  • Official: To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill's Views

  • Today: 1
  • Past Seven Days: 4
  • All-Time: 1,735
 
Introduced
 
House
Passes
 
Senate
Passes
 
President
Signs
 

 
01/09/07
 
 
 
 
 
 
 

Sponsor

View Co-Sponsors (109)

Official Summary

1/10/2007--Introduced.Pharmaceutical Market Access and Drug Safety Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported

Official Summary

1/10/2007--Introduced.
Pharmaceutical Market Access and Drug Safety Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States. Prohibits the importation of a qualifying drug unless such drug is imported by:
(1) a registered importer; or
(2) an individual for personal use. Establishes registration conditions for importers and exporters. Requires the Secretary to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions. Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences. Prohibits manufacturers from:
(1) discriminating against registered exporters or importers;
(2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country;
(3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or
(4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug. States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement. Requires the Secretary to educate consumers regarding prescription drug importation. Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA. Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.


...Read the Rest

FEED

Recent News Coverage

 |  View Top Rated

09/12/07
NFIB Shouldn't Support Drug Reimportation Bill

... Federation of Independent Business -- which recently announced support for the Pharmaceutical Market Access and Drug Safety Act (S 242 and HR 380), ...

Source: eMaxHealth.com, NC
Add to My Political Notebook Save to Notebook Rate
03/06/07
AARP Presses Case for Rx Importation

In January, AARP endorsed the bipartisan "Pharmaceutical Market Access and Drug Safety Act of 2007" (S. 242, HR 380), which would legalize the importation ...

Source: PharmaLive.com (press release), PA
Add to My Political Notebook Save to Notebook Rate
03/06/07
AARP Presses Case for Rx Importation

In January, AARP endorsed the bipartisan "Pharmaceutical Market Access and Drug Safety Act of 2007" (S. 242, HR 380), which would legalize the importation ...

Source: PR Newswire (press release), NY
Add to My Political Notebook Save to Notebook Rate
FEED

Recent Blog Coverage

View All (80)  |  View Top Rated

01/24/11
Fleshing out the DUI Debate with a few Statistics « 4&20 blackbirds

As the Montana legislator considers multiple bills concerning Montana's most notorious cultural trait I'm sure that a lot of people around Montana are happy that this state might be getting a little more serious about ...

Add to My Political Notebook Save to Notebook Rate
12/30/08
Eye on FDA: Welcome 2009 - What's in Store for the Pharmaceutical ...

H.R. 380 - Pharmaceutical Market Access and Drug Safety Act of 2007 · H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 · H.R. 63 - RU-486 Suspension and Review Act of 2007 · H.R. 780 - Counterfeit Drug Prevention Act o

Source: Eye on FDA
Add to My Political Notebook Save to Notebook Rate
12/28/08
Eye on FDA: New Prostate Cancer Treatment Approved by FDA

H.R. 380 - Pharmaceutical Market Access and Drug Safety Act of 2007 · H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 · H.R. 63 - RU-486 Suspension and Review Act of 2007 · H.R. 780 - Counterfeit Drug Prevention Act o

Source: Eye on FDA
Add to My Political Notebook Save to Notebook Rate









Vote on This Bill

-% Users Support Bill

0 in favor / 0 opposed
 

Send Your Rep a Letter

about this bill Support Oppose Tracking
Track with MyOC
Save to Notebook Make A Bill Widget

OpenCongress is a free and open-source project of the Participatory Politics Foundation, a 501(c)3 non-profit organization with a mission to increase civic engagement. The non-profit Sunlight Foundation is the Founding and Primary Supporter of OpenCongress.